What Is the Glycemic Index of Peanut Butter?

Peanut butter has a glycemic index of about 14, placing it firmly in the low-GI category. For context, any food scoring below 55 is considered low-GI, so peanut butter sits at the very bottom of that range. This matters because peanut butter is one of the most commonly consumed foods that people wonder about when managing blood sugar, and the answer is reassuringly simple: on its own, it barely moves the needle. What gets more interesting is what happens when you pair peanut butter with foods that do spike blood sugar.

Why Peanut Butter Scores So Low

A food’s glycemic index reflects how quickly it raises blood sugar compared to pure glucose, which is the reference point at 100. Peanut butter’s GI is low because its macronutrient profile works against rapid glucose absorption at every step. Roughly half the calories in peanut butter come from fat, and another quarter come from protein. Both fat and protein slow gastric emptying, meaning the stomach takes longer to pass food into the small intestine where carbohydrates get absorbed. Peanut butter also contains relatively little carbohydrate to begin with: a two-tablespoon serving has only about 6 to 8 grams of total carbs, and a couple of those grams are fiber.

This combination of modest carbohydrate content, high fat, decent protein, and some fiber means peanut butter triggers very little insulin demand on its own. You could eat a generous serving and see almost no change in a continuous glucose monitor reading. That is unusual for a food this calorie-dense, and it is one reason peanut butter gets recommended so frequently in diabetes management plans.

The Real Value: What Peanut Butter Does to Other Foods’ Blood Sugar Impact

The more practical question for most people is not what peanut butter does alone but what it does when paired with higher-GI foods like bread, crackers, or oatmeal. Research here is consistent and encouraging. A pilot study that gave participants a high-GI meal with two tablespoons of peanut butter found the blood sugar spike dropped by about 30 percent compared to eating the same meal without peanut butter. Blood sugar was measurably lower at 15, 30, and 60 minutes after eating.¹

This is not a new observation. As far back as the 1980s, researchers noted that adding peanut butter to bread reduced the glycemic response, even when other additions like butter or cheese did not have the same dampening effect.² The combination of fat and protein in peanut butter seems to be particularly effective at slowing carbohydrate absorption compared to adding fat or protein from other sources. A randomized trial in overweight adults with prediabetes found that a higher-protein nut-based snack reduced the glucose response to co-ingested carbohydrate by roughly 25 percent.³

In plain terms, spreading peanut butter on toast meaningfully reduces the blood sugar impact of the toast. Stirring it into oatmeal does the same. The effect is real, it is reproducible, and it works with a realistic serving size rather than some impractical laboratory dose.

The Second-Meal Effect

One of the more useful findings about peanut butter and blood sugar extends beyond the meal you eat it with. A clinical trial in obese women at high risk for type 2 diabetes found that eating peanut butter at breakfast lowered glucose levels not just during that meal but also during the following meal eaten hours later.⁴ Participants also reported feeling less desire to eat after the peanut butter breakfast, and their gut satiety hormones reflected that reduced appetite.

This “second-meal effect” is particularly relevant if you tend to eat a carbohydrate-heavy lunch. Having peanut butter earlier in the day appears to prime your metabolism to handle the next influx of carbs more smoothly. The mechanism likely involves sustained insulin sensitivity and slower gastric emptying that carries over, though researchers are still working out the exact pathway. From a practical standpoint, it suggests peanut butter at breakfast could be one of the more strategically useful times to eat it if blood sugar management is your goal.

Does Regular Peanut Butter Consumption Lower Diabetes Risk?

Short-term blood sugar responses are one thing, but people also want to know whether eating peanut butter regularly offers longer-term protection. A large study following over 83,000 women in the Nurses’ Health Study found that women who ate peanut butter five or more times per week had about a 21 percent lower risk of developing type 2 diabetes compared to women who rarely or never ate it.⁵ The relationship held after adjusting for other dietary and lifestyle factors.

Observational studies like this cannot prove that peanut butter itself causes the reduction. Women who eat peanut butter five times a week may differ in other ways from women who avoid it, and some of those differences could explain part of the association. But the magnitude and consistency of the finding across a very large cohort, combined with the known short-term metabolic effects, makes the case fairly persuasive that regular peanut butter consumption is at least not harmful and probably beneficial for blood sugar regulation over time.

Added Sugar Changes the Math

Not all peanut butter is the same when it comes to glycemic impact. The standard natural peanut butter, the kind with just peanuts and maybe salt on the label, has the GI of about 14 described above. But many commercial peanut butters contain added sugars, hydrogenated oils, and other ingredients that nudge the carbohydrate content upward. A highly sweetened variety might have 3 to 5 additional grams of sugar per serving. That may not sound like much, but it shifts the glycemic load of the serving upward by a meaningful fraction.

Reduced-fat peanut butters are a more insidious problem. When manufacturers remove fat, they typically replace it with more sugar or starch to maintain flavor and texture. This trades away the very component of peanut butter (fat) that gives it its blood-sugar-blunting properties, while adding carbohydrate. For someone specifically trying to manage blood sugar, reduced-fat peanut butter is counterproductive. It has a higher glycemic load than regular peanut butter and less of the fat that slows glucose absorption.

If you are choosing peanut butter for metabolic reasons, the ingredient list matters more than the front label. The ideal list reads “peanuts” or “peanuts, salt.” Any version where sugar appears in the first three ingredients will behave differently in your bloodstream than the numbers in most glycemic index tables suggest, since those tables are generally based on natural or minimally processed varieties.

Glycemic Index Versus Glycemic Load

A GI of 14 sounds impressive, but there is a reason nutritionists often prefer a related measure called glycemic load. GI tells you how fast a food’s carbohydrates raise blood sugar on a gram-for-gram basis, but it does not tell you how many grams of carbohydrate are actually in a normal serving. Glycemic load multiplies the GI by the grams of carbohydrate per serving and divides by 100, giving you a practical estimate of total blood sugar impact.

For peanut butter, the glycemic load of a two-tablespoon serving works out to roughly 1. Anything under 10 is considered low. So peanut butter scores near the very bottom on both scales. This is partly why it is such a useful blood sugar management food: even if you eat more than a standard serving, the glycemic load stays small because there simply is not much carbohydrate to absorb.

Compare that to something like watermelon, which has a high GI (around 72) but a low glycemic load per serving because a cup of watermelon does not contain much total carbohydrate. Both watermelon and peanut butter have low glycemic loads, but for different reasons. Peanut butter achieves it by having both a low GI and low carb content, which makes it especially reliable as a blood sugar anchor.

Peanut Butter and Gut Health

Emerging research suggests that peanut butter’s metabolic benefits may partly operate through changes in the gut microbiome. Peanuts are rich in polyphenols and fiber, both of which feed beneficial gut bacteria. A review of the evidence found that peanut consumption promotes the growth of bacteria that produce short-chain fatty acids, which are linked to improved insulin sensitivity and reduced inflammation.⁶ The review also connected peanut-driven microbiome changes to improvements in metabolic syndrome risk factors, particularly when the baseline diet was high in fat.

This line of research is still developing, and nobody should eat peanut butter primarily for its prebiotic effects. But it adds a plausible biological explanation for why regular peanut consumption tracks with better metabolic health in large observational studies. The benefits may not be purely about what peanut butter does in the hours after you eat it; some of the effect may accumulate over weeks and months as your gut bacteria population shifts.

Practical Considerations for Blood Sugar Management

If you are eating peanut butter specifically to help manage blood sugar, a few practical points are worth keeping in mind:

Serving size: Two tablespoons is the amount used in most of the research. That provides about 190 calories, so it is easy to overdo if you are not measuring. The blood sugar benefits plateau once you have enough fat and protein to slow gastric emptying, so tripling the serving does not triple the benefit.
Timing: Pairing peanut butter with a carbohydrate-containing meal or snack gives you the most glycemic benefit. Eating it alone when your blood sugar is already stable provides less noticeable impact, though it still serves as a low-GI snack that will not cause a spike.
Consistency: Regular consumption appears to matter more than occasional large doses. The observational data on diabetes risk reduction pointed to frequency of intake, not amount per sitting.

People taking insulin or sulfonylureas should be aware that adding peanut butter to a meal they have already dosed insulin for could theoretically cause blood sugar to drop lower than expected, since the carbohydrate will absorb more slowly. This is a conversation for your diabetes care team, not something to guess about.

Peanut Butter Versus Other Nut Butters

Almond butter, cashew butter, and other nut butters are often marketed as healthier alternatives. In terms of glycemic index, most nut butters fall in a similar low-GI range. Almond butter has slightly more fiber and slightly less carbohydrate per serving than peanut butter, but the practical difference in blood sugar response is small. Cashew butter has somewhat more carbohydrate and a slightly higher GI, though still well within the low range.

Where peanut butter has the strongest advantage over alternatives is in the research base. The studies on glycemic response, second-meal effects, and long-term diabetes risk have been done specifically with peanut butter or peanuts, not with almonds or cashews. That does not mean other nut butters are worse for blood sugar, only that the evidence directly supporting them is thinner. The basic mechanism of fat and protein slowing carbohydrate absorption applies to all nut butters, so they likely have similar effects. But if someone asks you which nut butter has the most data behind it for blood sugar management, peanut butter wins by a wide margin simply because it has been studied more often and in larger populations.

Price matters here too. Peanut butter is consistently one of the least expensive nut butters, often costing half or a third as much as almond butter. If the glycemic benefits are comparable and the research support is stronger, peanut butter is a hard option to argue against on practical grounds.

Who Should Be Cautious

Peanut allergy is the obvious red flag, and it is worth stating plainly: no blood sugar benefit is worth an allergic reaction. People with peanut allergies should look to tree nut butters or seed butters like sunflower seed butter for similar metabolic effects.

Aflatoxin contamination is a concern that surfaces occasionally in discussions of peanut products. Peanuts grow underground and are susceptible to a mold that produces aflatoxins, which are carcinogenic at high levels. In practice, commercial peanut butter in the United States and Europe is tested and regulated, and aflatoxin levels in finished products are kept well below safety thresholds. This is a more relevant concern for raw peanuts stored in humid conditions, not for commercially processed peanut butter.

People with kidney disease on protein-restricted diets may need to limit peanut butter because of its protein and phosphorus content, separate from any glycemic considerations. And anyone following a very low-calorie diet should be mindful that peanut butter is calorie-dense. Two tablespoons deliver nearly 200 calories, which is a meaningful fraction of a restricted daily total. The blood sugar benefits are real, but they do not exempt peanut butter from basic calorie arithmetic.